Atlas Trials

Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine

Clinical trial NCT06291779 · UNKNOWN

Trial details

NCT number
NCT06291779
Sponsor
Ho-Seong Han
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreas CancerDiagnosis
Start date
2022-11-30
Primary completion
2024-02-26
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.